NCT00807677: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies |
|
|
| Completed | 1 | 31 | US | TAK-901 | Millennium Pharmaceuticals, Inc. | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Waldenstrom's Macroglobulinemia, Myelodysplastic Syndrome, Philadelphia Chromosome-negative CML, Myeloid Metaplasia, Myelofibrosis, Advanced Polycythemia, Non-Hodgkins Lymphoma | 09/12 | 03/13 | | |
